Drug Trial Radar · NCT01380353
Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine
Last checked: Nov 20, 2026Latest source record: Feb 19, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Jun 2011
Primary completion
Nov 12, 2012
Study completion Nov 12, 2012
Sponsor
- Lead sponsor
- Northwestern UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 27, 2011
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to look for ways to improve breast cancer treatment by giving breast cancer drugs through the skin of the breast. The drug used in this study is a diclofenac epolamine patch and is a nonsteroid anti-inflammatory pain reliever. The drug amount that gathers in the breast, after application of a patch to the skin of the breast, will be measured and compared to the amount that is found in the breast when the patch is applied to the skin of the belly.
Conditions
- Breast Cancer
Interventions
Diclofenac epolamine patchDrug
Patch (10cm X 14cm) is comprised of an adhesive material containing 1.3% diclofenac epolamine which is applied to a non-woven polyester felt backing and covered with a polypropylene film release liner \[B\].
Primary outcomes
What the sponsor says the trial is designed to measure.
- Compare concentrations of diclofenac epolamine patch when applied to breast vs. abdomenTime frame: after 3 days of treatment prior to surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Northwestern University
Chicago, Illinois
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.